1. Home
  2. SRRK

as 05-30-2025 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.

Founded: 2012 Country:
United States
United States
Employees: N/A City: CAMBRIDGE
Market Cap: 2.8B IPO Year: 2018
Target Price: $42.17 AVG Volume (30 days): 1.1M
Analyst Decision: Strong Buy Number of Analysts: 6
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.78 EPS Growth: N/A
52 Week Low/High: $6.76 - $46.98 Next Earning Date: 05-14-2025
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 452.64%

SRRK Daily Stock ML Predictions

Stock Insider Trading Activity of Scholar Rock Holding Corporation (SRRK)

Name Ticker Relationship Date Transaction AVG Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
Sacco Tracey SRRK Chief Commercial Officer Apr 25 '25 Sell $33.15 5,000 $164,130.79 71,750
Sacco Tracey SRRK Chief Commercial Officer Mar 24 '25 Sell $33.30 6,500 $215,014.05 71,750
Moore Erin SRRK Interim PFO and PAO Mar 24 '25 Sell $33.12 13,564 $449,236.97 82,609
Peng Katie SRRK Director Mar 17 '25 Sell $34.42 1,006 $34,626.92 30,319
Myles Edward H SRRK COO & CFO Mar 10 '25 Sell $35.35 142,292 $5,068,974.19 140,740

Share on Social Networks: